Verbatim response from Claude
Compounded Tirzepatide Availability (as of early 2025)
This is a rapidly changing situation, so here's what you should know:
The Current Status
The FDA removed tirzepatide (Zepbound/Mounjaro) from its drug shortage list in late 2024, which means most compounding pharmacies had to stop producing it by early 2025 under federal rules.
Potentially Legitimate Options Still Worth Checking
- Empower Pharmacy - A 503B outsourcing facility that had more flexibility; check their current status directly
- Belmar Pharmacy - Another compounding pharmacy worth contacting
- Strive Pharmacy - Has offered compounded GLP-1s
Important Caveats
- 503B outsourcing facilities have more regulatory leeway than standard compounding pharmacies
- Some providers may still offer it legally for specific patient circumstances
- The landscape changes week to week with ongoing FDA and legal battles
What I'd Recommend
- Consult a telehealth provider like Hims & Hers, Henry, or a local obesity medicine doctor
- Ask specifically about current legal compounding options
- Check if you qualify for manufacturer savings programs for brand-name Zepbound
Always verify current FDA guidance before purchasing, as this situation is actively evolving.